Proven Performance Across Three Pivotal Studies

The PRECISE and PRECISE II trials investigated the system’s accuracy, longevity and safety, along with glycemic control data and self-reported quality of life. The PRECISION study captured additional data on safety and accuracy. Combined, the three studies supported the clinical efficacy of Eversense and its exceptional long-term accuracy and wear time.

 

The PRECISE II (U.S.) Trial

The second study (PRECISE II), performed in the United States, investigated the efficacy and safety of the Eversense CGM System during 90 days of continuous sensor wear...

The PRECISION Trial

This trial was designed to provide additional data on the Eversense CGM system across three metrics...